Dr. Benjamin David Schultz, MD

Dr. Schultz practices at Surgical Specialty Suites in Lutherville, Maryland.

Dr. Schultz's NPI, 1689069692, was assigned on April 6, 2015. Dr. Schultz graduated from University of Maryland School of Medicine in 2015. Dr. Schultz holds Maryland license D91045.

Dr. Schultz's primary practice is Surgical Specialty Suites, at 1304 Bellona Avenue, Lutherville, MD 21093. The practice phone is (410) 616-3000.

Dr. Schultz's primary practice is Surgical Specialty Suites in Lutherville, Maryland. Dr. Schultz is also affiliated with Sinai Hospital of Baltimore. The medical group on file is Lutherville Pediatrics. Dmand AI also links Dr. Schultz to 1 more hospital, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schultz practices, 4 sites in all. Vendor and product names are available with a free account.

Surgery is Dr. Schultz's primary specialty in the NPI Registry, under taxonomy code 208600000X. Dr. Schultz is licensed in Maryland.

CMS data shows 102 Medicare services from Dr. Schultz across 4 procedure codes in 2024, all of them office visits, for 94 Medicare patients. Medicare paid $8,925 for them. Every service was in an office.

CMS counts 94 Medicare patients who saw Dr. Schultz in 2026. The largest group is 65 to 74, with 52 patients. 75% of them have high cholesterol, and 71% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.05, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Schultz's median patient age at 49, with 80% women.

In 2026, Dr. Schultz wrote 148 Medicare Part D claims for 31 patients. 99% of them were for generic drugs. CMS names the drug for 113 of them, across 5 drugs with 11 or more claims each, at $588 in total drug cost. In 2023, CMS named 82 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. Schultz for performance year 2026, reported as part of a group. Dr. Schultz accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 13 procedures of mastectomy by Dr. Schultz, more than 68% of the clinicians it reports for that procedure.

Laminectomy or laminotomy (partial removal of spine bones): 1 to 10 procedures (CMS shows small counts as a range)

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of skin lesions: 1 to 10 procedures (CMS shows small counts as a range)

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Spinal fusion: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 12 papers to Dr. Schultz, published from 2018 to 2022. The most frequent topics are Breast Neoplasms, Mammaplasty and Plastic Surgery Procedures. Dr. Schultz has published most often in Plast Reconstr Surg. Dr. Schultz's most frequent co-authors are Neil Tanna, MBA, MD, Amir Hossein Dorafshar, MD and Michael R. Christy, MD.

CMS Open Payments shows 57 general payments to Dr. Schultz from 16 drug and device companies from 2021 to 2025. Food and beverage make up the largest share, 76% of the total. AxoGen paid the most, $1,197.

Dr. Schultz graduated from University of Maryland School of Medicine in 2015.